Showing 1 - 5 results of 5 for search 'Liubao Peng', query time: 0.03s Refine Results
  1. 1
    Clinical efficacy and safety of 16 Chinese patent medicines in combination with benzodiazepines/non-benzodiazepines for the treatment of chronic insomnia in adults: A multiple-treatment meta-analysis

    Clinical efficacy and safety of 16 Chinese patent medicines in combination with benzodiazepines/non-benzodiazepines for the treatment of chronic insomnia in adults: A multiple-trea... by Ciyan Peng, Jing Chen, Sini Li, Boyin Huang, Wei Cui, Jianhe Li, Liubao Peng

    Published 2024-06-01
    Get full text
    Article
  2. 2
    Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA

    Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA by Xiaohui Zeng, Xiaomin Wan, Liubao Peng, Ye Peng, Fang Ma, Qiao Liu, Chongqing Tan

    Published 2019-12-01
    Get full text
    Article
  3. 3
    Comparative efficacy and safety of various Chinese patent medicines combined with western medicine for adults with insomnia: A Bayesian network meta-analysis of randomized controlled trials

    Comparative efficacy and safety of various Chinese patent medicines combined with western medicine for adults with insomnia: A Bayesian network meta-analysis of randomized controll... by Ciyan Peng, Jing Chen, Sini Li, Boyin Huang, Wei Cui, Jianhe Li, Liubao Peng

    Published 2023-09-01
    Get full text
    Article
  4. 4
    Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China

    Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China by Xiaohui Zeng, Xiaomin Wan, Liubao Peng, Qiao Liu, Chongqing Tan, Xia Luo, Lidan Yi

    Published 2020-11-01
    Get full text
    Article
  5. 5
    Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.

    Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis. by Xiaohui Zeng, Jianhe Li, Liubao Peng, Yunhua Wang, Chongqing Tan, Gannong Chen, Xiaomin Wan, Qiong Lu, Lidan Yi

    Published 2014-01-01
    Get full text
    Article

Search Tools: